Glilot Capital Partners leads round joined by a network of high-profile CISOs and angel investors

NEW YORK, Feb. 22, 2023 — Entitle today announced that it has exited stealth with $15 million in seed financing and launched its cloud permissions management platform. The round was led by Glilot Capital Partners with participation by angel investors including more than 10 CISO’s from Unicorn companies. Founded in 2021 by two former members of an elite team within the Israel Defense Force’s renowned Unit 8200, Entitle applies their expertise in deep learning, security operations and vulnerability research to deliver a cloud permissions management platform that fuses a security-first approach with a commitment to business enablement.

With the rapid adoption of cloud-based apps and infrastructure, IT and DevOps teams find themselves responsible for hundreds of thousands of permissions. Outnumbered and without consolidation or automation, security teams struggle to strike the right balance between being over-permissive to enable the business and giving just enough access to ensure security. This has caused crisis levels of entitlement sprawl, with security teams lacking the visibility and control needed to fix it, until now.

Introducing Entitle’s Cloud Permission Management Platform:
Entitle’s SaaS-based platform transforms how employees access cloud-based resources. It automates access requests and grants to prevent entitlement sprawl and save IT and DevOps teams a significant amount of effort. Entitle eliminates provisioning-related bottlenecks so security leaders can painlessly enforce the Principle of Least Privilege while maintaining a seamless user experience. Entitle’s platform features:

• Self-Service Requests and Decentralized Approvals: Employees request the permissions they need via Slack, Teams, Jira, or email. With Entitle driving the approval process, IT and DevOps teams are no longer solely accountable for approving requests from people they don’t know to apps they’re not responsible for. Approval decisions are delegated to business unit owners for better context and authorizations that Security can trust.
• Dynamic Provisioning: Entitle speeds up access grants to enable security teams to create dynamic authorization policies that change with dynamic infrastructure and employee needs. This includes the ability to provide just-in-time access to sensitive resources, ensuring permissions are only given when needed and removed once they are not. Security can set fine-grained access control policies for specific resources, be it a Google Drive folder or a Git repository.
• Visibility, Governance, and Access Reviews: Instead of governing permissions across thousands of isolated resources, Entitle provides a centralized view of all permissions that employees and contractors have or had. Every access-related action is logged including who asked for permission, to what, who signed off on it, and why, establishing governance and automating the tasks involved with demonstrating support for SOC2, SOX and other compliance mandates. 

“As a cloud-native, digital insurance company, we approach security, audit, and compliance with the bionics of automation. Using Entitle, we’ve implemented self-service, just-in-time provisioning that follows proper security practices,” said Jonathan Jaffe, CISO, Lemonade, Inc. “Entitle made us more secure and delivers automation that saves us time and makes our team happy. For me, it has reduced much of the pain of access reviews and audits.”

“We invested in Entitle because its approach to solving the thorny, long-standing challenges of automatic provisioning stood out from the pack. Its platform is comprehensive, technically elegant, and the market is in real need for this type of solution,” said Arik Kleinstein, Co-founder and Managing Partner at Glilot Capital Partners.” We look forward to supporting the company as it executes on its vision to deliver frictionless permissions management.”

“Our expertise in the IDF was in operational security and the core problems underlying permissions management are operational. Entitle enables us to apply our military training to solve a tough, long standing IT problem,” said Ron Nissim, co-founder and CEO, Entitle. “The Entitle platform takes the risk management burden off DevOps teams and onto security, where it belongs. Our security-first approach eliminates the tradeoff between security and productivity and we’re excited to show what we bring to the table.”

About Entitle
Entitle has developed a Cloud Permissions Management platform that enables cybersecurity leaders to control access to cloud resources without friction and pushback. Its self-service platform automates provisioning and establishes access governance across complex, highly dynamic, multi-cloud environments. The company is backed by Glilot Capital and a network of high-performing CISOs and security entrepreneurs. Founded in 2021 by former members of the IDF’s elite Unit 8200, Entitle leverages their expertise in deep learning, security operations and vulnerability research to provide security teams with the ability to control, secure and audit access control processes. Entitle’s product is generally available, with customers including Lemonade, At-bay, K-Health, Bilt, and Hippo. For more information visit https://www.entitle.io

Media Contact:
Elizabeth Sarfan
408-348-1214
[email protected]

SOURCE Entitle

Funds raised will accelerate company’s launch

SAN JOSE, Calif., Feb. 22, 2023 — The Atsign Company, (“Atsign”), a technology company that makes it easy to secure the privacy of individuals, organizations, and things on the Internet, announced today the launch of their capital raise campaign on the Republic platform at https://republic.com/atsign. U.S. and International investors may purchase equity in Atsign via a SAFE note.

Atsign’s award-winning technology platform (the “atPlatform”) allows IoT (Internet of Things) device manufacturers and integrators to secure connected devices better than any other current technology, giving device administrators remote access with zero network attack surfaces, zero static IP addresses, and end-to-end encryption. The atPlatform also makes it easy for enterprise and consumer app developers to build privacy-first applications that give individuals control over what personal data they share, with whom they share it, and how long the data is available. 

Since 2019, Atsign has raised $11M from Angel investors and aims to grow to $14M with this current round. The company is looking to raise $1M from the community and $1M from private investors to add to a $1M commitment already obtained from Angel investors. Atsign will use the new round of funding to complete and execute their go-to-market strategy in the $6B IoT security market.

“As a company, we are always looking for ways to prioritize people and the planet,” said Barbara Tallent, co-founder and CEO of Atsign. “We’re really excited to give our community of privacy advocates, cyber-security professionals, and retail investors the opportunity to make a difference in the world and improve their investment portfolios at the same time.”

Learn more about investing in Atsign.

About Atsign

Atsign is an award-winning technology company that believes the privacy and security of every person, organization, and device is a fundamental right, and they’re working towards making it a reality. They won the 2022 IoTSF Champion award and the 2023 IoT Global Award for Securing IoT.

Learn more at Atsign.com.

SOURCE Atsign

Energy-efficient splitting of nanostructures on silicon attracts investors like Navigare Ventures and Almi Invest

LUND, Sweden, Feb. 22, 2023 — AlixLabs, an innovative Swedish startup in the semiconductor industry, today announces that the company has closed a funding round of SEK 10 million. The investment comes from, among others, the Wallenberg sphere’s venture capital fund Navigare Ventures, Almi Invest, and the ice hockey family Nylander. AlixLabs will mainly use the capital injection to commercialize the company’s innovative Atomic Layer Etching (ALE) Pitch Splitting technology (APS). APS enables more cost-effective manufacturing of future advanced semiconductors.

– Advanced semiconductor manufacturing is spiraling in cost due to extremely costly lithography equipment (EUV), which also requires massive energy to operate. It is especially noticeable in the price of processors that power everything from mobile phones and computers to Internet servers. With our patented APS technology, the handful of companies with the most advanced semiconductor manufacturing fabs can reduce the number of process steps and save time, energy, and climate-impacting emissions. We are proud to be able to continue to develop this technology in Sweden with the support of our investors, says Jonas Sundqvist, CEO, AlixLabs.

– We invest in companies based on science and leading-edge technology, enabling tomorrow’s industry. AlixLabs is paving the way toward a more sustainable future for semiconductor manufacturers. We also look forward to a more innovative semiconductor industry in Sweden that can contribute at the EU level, says Alex Basu, Investment Manager at Navigare Ventures.

Background

Modern transistors, the basis of almost all the electronics we take for granted today, has evolved to build on raised silicon fin and nanowire structures. AlixLab’s process makes it possible to split a 40-nanometer-wide feature into two features of 10 nanometers at half the pitch, which can form the basis of transistors or electrical contacts and metal interconnects. The process is scalable to smaller structures below 10 nm. It is unique in that it takes place with the help of energy-efficient etching, which reduces the use of additional expensive and energy-consuming lithography equipment.

The European Union has identified the semiconductor sector and its associated chip manufacturing as an area of particular interest. During Sweden’s presidency in 2023, the semiconductor act EU Chips Act is expected to become a reality, which is scheduled to deploy just over 43 billion euros for semiconductor companies within the Union over five years. The goal of the Chips Act is that by 2030, 20 percent of the world’s semiconductors will be manufactured within the Union. The global market is predicted to exceed one trillion (1,000 billion) euros by the next decade, up from today’s approximately 450 billion euros.

– Of these trillion euros by 2030, almost half of the sales will come from advanced segments that can use our APS technology to simplify manufacturing. Our goal is that the process we have developed will be used by circuit manufacturers in their most advanced manufacturing starting in 2025,” concludes Jonas Sundqvist.

CONTACT:

Jonas Sundqvist, CEO of AlixLabs, phone +46 767 63 94 67, email: [email protected] 

The following files are available for download:

SOURCE AlixLabs AB

With seed funding co-led by Gutter Capital and Crossbeam Venture Partners, the company launches its full-service homebuilding platform

HUDSON VALLEY, N.Y., Feb. 21, 2023 — DEN Outdoors (DEN), the home design and construction management company, today announced the close of its seed funding round, raising a total of $3 million. Co-led by Gutter Capital and Crossbeam Venture Partners, the financing allows DEN to continue innovating across the home design and construction industries and roll out its latest expansion, BuiltBy DEN.

Since its founding in 2020, DEN has featured a curated collection of high-quality, design-minded modern cabin plans, helping aspiring homeowners build beautiful homes close to nature for far less than the cost of a traditional firm.

BuiltBy DEN takes the DEN offering one step further and provides homebuyers with a streamlined construction experience featuring curated designs, land selection, customizations, builders, and end-to-end project management — all in one platform for the customer to see updates in real-time. Buying and building a new home will be just as easy as purchasing a car with this latest offering, as each customer will have access to a DEN representative who will facilitate all major stages of the homebuilding process for the future homeowner, ensuring ease, transparency, and quality throughout.

“Sharing the DEN designs with the world has been so fulfilling, watching customers all over the globe bring these beautiful, modern cabins to life. And yet so many more potential customers are stuck, without the time, energy, or knowledge to manage a home build. I get it — I went through the process myself and it’s extremely overwhelming and outdated. I’m really excited to merge the world of tech and homebuilding to create a seamless home buying experience that no one has seen before — one that results in customers unlocking a delightfully crafted, modern home that’s their own personal retreat.”

Founded by CEO Mike Romanowicz at the start of the pandemic, DEN has seen explosive organic revenue and community growth with an energetic following of over 120,000 individuals at @denoutdoors.

“Conventional wisdom says that custom housing takes twice as long and costs twice as much, Mike and his team at DEN have proven this is not true,” said Dan Teran, Co-Founder and Managing Partner at Gutter Capital. “We have had the privilege of watching this team execute over the past year, and we believe that DEN has an opportunity to meaningfully accelerate the pace of housing development at a time of crisis.” Prior to founding Gutter Capital, Teran was the Co-Founder and CEO of Managed by Q (acquired: $WE), and Global Head of Corporate Development and Ventures at WeWork. Teran has joined the DEN Board of Directors.

“We believe DEN is revolutionizing the consumer homebuilding space including simplifying the now click-to-buy experience to be as stress-free as possible for customers,” said Ryan Morgan, Managing Director at Crossbeam. “With extensive employee knowledge across nearly all sectors of design, homebuying, and construction, the team is well-positioned to continue to grow the business at scale.”

BuiltBy DEN will initially be offered in the Hudson Valley and Catskills region of upstate New York, with expansion markets to quickly follow across the US.

About DEN Outdoors
DEN was founded in July 2020 as a home design and construction management company dedicated to inspiring people everywhere to take the leap and build a premium, modern home nestled in nature. Today, we serve a diverse global community of dreamers, DIYers, and doers who are as enthusiastic as we are about bringing the outdoors in. Based in upstate New York with a distributed team across the United States, DEN is committed to an intentional balance of premium design, sustainable living, and a connection to the natural world. For more information, visit: https://denoutdoors.com/

About Gutter Capital
Gutter Capital is a hard working venture firm based in New York City. Gutter partners with mission driven founders to build companies of consequence, addressing the greatest challenges facing society – namely affordability, economic mobility, and climate change. For more information, visit https://gutter.cc/.

About Crossbeam Venture Partners
Crossbeam Venture Partners (Crossbeam) is a venture capital firm that invests in Pre-Seed and Series A startups building tomorrow’s economy. Focused on the themes of platform economies, fintech, new forms of media, and alternative sources of income, Crossbeam is built to back companies of the next generation economy utilizing unique structures, credit, or novel business models. For more information, visit https://crossbeam.vc

Media contact: 
Emma Thomas
[email protected]

SOURCE DEN Outdoors

Funding will Propel Abilita Bio’s Preclinical Therapeutic Programs and Accelerate the Company’s Overall Growth

SAN DIEGO, Feb. 21, 2023 — Abilita Bio, a leader in discovering and developing membrane protein-targeted therapeutics, announced today that it raised $7.5M in equity financing from Two Bear Capital. The funds will help propel the company’s existing preclinical therapeutic programs, initiate efforts on additional targets, grow the team, and expand operations in San Diego. Mike Goguen, Managing Partner at Two Bear Capital, has joined Abilita Bio’s board.

“We are excited about Abilita Bio’s innovative Enabled Membrane Protein (EMP™) technologies. It is a novel and elegant approach that overcomes key technical hurdles that are currently impeding the development of therapeutics for challenging targets,” said Rachel Tsunemoto Hislop, PhD, a Principal at Two Bear Capital who spearheaded the investment. “We are honored to support Abilita Bio’s experienced team of membrane protein experts as they greatly expand the realm of what is possible.”  

GPCRs, ion channels, and transporters reside in the cell membrane and are the targets of about 60% of today’s medicines, highlighting their medical importance. However, only 15% of these proteins are drugged. In addition, only two of the 100 FDA-approved antibody therapeutics target these challenging proteins. This discrepancy results from a massive technology gap that spans 25 years. Abilita Bio is poised to bridge this gap using its proprietary technologies. Currently, the company has four active therapeutic antibody programs and is looking to move its first asset toward the clinical development candidate stage, as well as building partnerships with industry leaders that span from biologics to small molecules.

In addition, Dr. Michael Hanson recently joined the Abilita Bio team as CSO. He brings a strong track record of drug discovery and development in the GPCR space and most recently propelled multiple compounds into the clinic during his tenure at ShouTi (now Structure Therapeutics), where he was co-founder and CTO. Dr. Hanson also brings deep expertise in GPCR small molecule drug discovery, structural biology, structure-based drug design, and computational methods.

“Membrane proteins are notoriously difficult to drug. With our EMP platform, we are able to address the root cause of failures. This lets us reach beyond lower-hanging fruit to access the entire tree of promising membrane targets. We are now working to become the leader in the space,” said Mauro Mileni, PhD, CEO & Founder.

About Two Bear Capital

Two Bear Capital (TBC) was founded and is led by veteran Silicon Valley venture capitalist and philanthropist Michael Goguen. Two Bear Capital seeks to invest in the most promising early-stage companies solving some of today’s most urgent problems at the intersections of healthcare, biotechnology, bioinformatics, artificial intelligence/machine learning, cybersecurity, and software infrastructure for enterprise. Two Bear Capital’s investment team is based in Whitefish, Montana, the San Francisco Bay area, San Diego, and Boston. To learn more, visit www.twobearcapital.com and follow Two Bear Capital on LinkedIn.

About Abilita Bio

Abilita Bio, Inc. is a privately held, innovation-driven biotechnology company focused on discovering and developing therapeutic antibodies targeting the most challenging and medically important multi-span membrane proteins. Abilita Bio’s validated drug discovery engine builds on the foundation of its powerful EMP™ target evolution platform and deep membrane protein expertise to a suite of internal antibody discovery technologies. For more information, visit www.abilitabio.com.

SOURCE Abilita Bio

New smart surgical needle and software-enabled surgical platform to allow for greater precision and range of curative treatments

WASHINGTON, Feb. 21, 2023 — Current Surgical Inc. today announced a $3.2 million seed funding round led by True Ventures, with participation from 1517 Fund and SciFounders. The Washington, DC-based medtech company is developing a software-enabled surgical platform to allow doctors to precisely and curatively treat a range of diseases. Since co-founders Alireza (Al) Mashal, PhD, and Chris Wagner, PhD, started Current Surgical in 2020, the company has raised $4 million in total, including a Small Business Innovation Research grant from the National Science Foundation.

Cancer continues to be a leading cause of death worldwide, with more than 18 million new cases detected every year. More than 50% of these cases are now detected at an early stage, yet curative options have not kept pace. For example, the only curative option for solid tumors is a surgical procedure. However, nearly 50% of patients are not eligible for surgery, because the tumor is too difficult to remove without damaging surrounding organs. Chemotherapy and radiation therapies, with their associated side effects, therefore remain the most common treatment options, which are non-curative for most cancers.

Current Surgical is addressing this lack of curative treatment by giving doctors a precision guided needle that can accurately destroy tumors, without harming surrounding healthy tissue, anywhere in the body. Current Surgical’s smart surgical needle technology combines high resolution sensors and real-time image analysis into one tool, giving doctors precise control and feedback while destroying tumors. As a result, surgeons will be able to treat any solid tumor in any location — allowing millions of patients to receive curative surgery without the traditional limitations.

“Technological advancements now allow us to detect cancers earlier and earlier, but the capability to treat those tumors hasn’t improved,” explains Current Surgical CEO Al Mashal. “We are bridging this gap through our smart needle technology. We want to give doctors the ability to curatively treat cancers in hard-to-reach places — without the harmful, debilitating side effects of other treatment options.”

“We’re excited about this technology not only for its curative potential, but also because of how easy it is to put into the hands of the surgeon,” says Current Surgical CTO Chris Wagner. “Since the technology is integrated into the needle, it doesn’t take a large, expensive operating room to actually help patients.”

“There’s so much to be excited about with Current Surgical,” said Natasha Sharma, principal at True Ventures. “Al and Chris have put their energy and deep experience with surgical robotics and biophysics into creating smart surgical needles that give surgeons ‘eyes inside’ so they can work with greater precision, like never before. This team also has immense compassion for the patients and customers who will benefit. We seek that in founders, and we can’t wait to see this work come to life.”

Current Surgical’s technology is automating key steps of surgery so doctors can instead focus on determining the best treatment for patients. Beyond treating even the most intractable diseases, the technology has wide-ranging applications, from treating cardiac arrhythmias and hypertension to other sources of chronic pain.

About Current Surgical
Current Surgical is a preclinical-stage company enabling a new generation of hybrid therapies through the development of smart surgical tools to allow doctors to precisely treat currently untreatable solid tumors. For more on Current Surgical, please visit www.currentsurgical.com and follow along on LinkedIn and Twitter @CurrentSurgical.

About True Ventures
Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early stage technology startups. With more than $3.8 billion under management, True provides seed and Series A financing to founders in some of today’s fastest growing markets. To date, True has helped more than 350 companies launch and scale their businesses, creating over 85,000 jobs worldwide. To learn more, visit www.trueventures.com.

SOURCE Current Surgical

New investments from Lockheed Martin Ventures, Hanwha Aerospace, and AIM13|Crumpton Venture Partners position Fortem
to meet growing market demand

PLEASANT GROVE, Utah, Feb. 21, 2023 — Fortem Technologies, a leader in airspace awareness, security, and defense, today announced that they have closed a funding round of $17.8 million led by new key industry investors including Lockheed Martin Ventures, Hanwha Aerospace, and AIM13|Crumpton Venture Partners. Existing investors DCVC and Signia Venture Partners have also contributed additional funds. The capital will help Fortem scale to meet growing demands across multiple regions and market sectors in airspace safety and security.

The Counter-UAS market continues to expand rapidly from a value of 685 million USD in 2019 to an estimated 4.7 billion USD by 2027. In addition, the Advanced Air Mobility market size was estimated at 8.93 billion USD in 2022 and is expected to hit around 45.12 billion USD by 2030. With Fortem’s support in Ukraine fighting suicide drones like the Shahed-136 and protecting world venues such as the World Cup Games in Qatar, the company is seeing this market growth and demand for their unique airspace awareness, security, and defense technology. This investment round will benefit the company’s strategy to be at the leading edge of this growing market.

“Rapid development and legitimate applications of UAS create an increasingly capable threat when in the hands of bad actors,” said Chris Moran, vice president and general manager of Lockheed Martin Ventures. “Lockheed Martin Ventures’ investment in Fortem Technologies signals our commitment to keeping pace with our customer’s requirements, ensuring the U.S. and its allies stay ahead of ready.”

“We are very pleased to invest in Fortem, a leading dual-use counter-UAS provider. The unique low collateral solution developed by Fortem will contribute to the growth of the c-UAS market globally and help to address the evolving UAS threats,” said a representative from Hanwha Aerospace. “Hanwha Aerospace is excited to support Fortem’s growth through the investment and continue to bring tremendous value across the sector.”

The investments from these industry-leading companies represents a significant endorsement for the growth and opportunity the company is seeing in the Counter-UAS and Advanced Air Mobility marketplace. Joining existing investors such as Boeing, Toshiba, Mubadala Investment Company, Signia Venture Partners, and DCVC, the new investors can also bring key industry insights and product development support as Fortem continues its aggressive growth strategy.

“We are extremely excited to be working with such respected companies in this funding raise,” said Jon Gruen, CEO of Fortem Technologies. “Not only does this investment help us address our rapidly growing market demand, but the level of support and industry experience these companies bring allows us to tap into unparalleled business, technical, and industry knowledge.”

About Fortem Technologies

Fortem Technologies is the leader in airspace awareness, security, and defense for detecting and defeating dangerous drones. Through an advanced, end to end system of distributed radar, AI at the Edge, deep sensor integration, and autonomous drone capture, Fortem monitors and defends the world’s venues, infrastructures, cities, and regions. The same system is accelerating the safety of the world’s airspace for urban air mobility. Based in Pleasant Grove, Utah, the company is privately held and backed by Toshiba, Boeing, DCVC, Mubadala Investment Company, Signia Venture Partners and others.

www.fortemtech.com

Contact:

Warren Brown
[email protected]

BAM for Fortem Technologies
[email protected]

SOURCE Fortem Technologies, Inc.

NEW YORK, Feb. 21, 2023 — TipLink, the easiest way to send and receive digital assets, today announced a $6M seed funding round co-led by Multicoin Capital and Sequoia Capital with participation from Asymmetric, Big Brain Ventures, Circle Ventures, Karatage, Monke Ventures, Paxos, and Solana Ventures, as well as well-known angels Vinny Lingham, Liu Jang and Sarah Guo. The funding will be used to further build out link wallet functionality, improve the API, and expand engineering and business development to support a pipeline of partnerships.

TipLink’s mission is to ease the distribution of crypto assets to accelerate the mainstream adoption of crypto. A TipLink is a link that is a crypto wallet. Using TipLink, anyone can deposit and send any form of digital asset—such as NFTs, stablecoins, Solana—to another person whether or not they already have a crypto wallet, which is not currently possible. TipLink can also be used as ultralight, non-custodial wallets that live in the browser.

“TipLink is the easiest and most versatile way to send and receive digital assets of all kinds,” said Ian Krotinsky, founder and CEO, TipLink. “There’s still a tremendous amount of friction in crypto that holds back mainstream adoption. It’s unreasonable to ask the general population to set up a 12- or 24-word seed phrase wallet, much less a hardware wallet, just to send a dollar or receive a commemorative NFT. TipLink solves one of the biggest problems in crypto: how to send digital assets in a frictionless way.”

TipLink has seen success since its beta launch in September at the Format Festival, where thousands of NFTs were claimed using QR codes and later spent for food and snacks—obscuring users from complicated crypto technology. Since then, TipLink has been used for everything from gifting, to payments, to giveaways.

“TipLink is a powerful new crypto primitive that represents the idea of ‘Digital Cash’ better than any other cryptocurrency, asset or tool on the market today,” said Spencer Applebaum, Principal, Multicoin Capital. “TipLinks will transform the way digital assets are shared in more casual settings and be a key enabler that help brands and companies experiment with and share digital assets in the future.”

TipLink also is launching today its simple API to help developers and companies generate and deposit any number of assets into any number of TipLinks. These TipLinks can then be embedded and shared in emails, text, messaging apps and QR codes, or any other means of digital communication. They are entirely channel agnostic, which makes them extremely versatile across the internet.

“TipLink explores a novel form factor that makes receiving any crypto asset easier than ever before,” said Daniel Chen of Sequoia. “We believe TipLink has the potential to onboard the first billion people into crypto, and we’re excited to partner with Ian and team as they deliver seamless cryptocurrency sharing.”

To learn more about TipLink, please visit https://tiplink.io/ or https://twitter.com/TipLinkOfficial. Contact at: [email protected].

SOURCE TipLink

Offshore Acquisition Expands Ventra Health’s Footprint into The Philippines

DALLAS, Feb. 21, 2023 — Ventra Health, a technology-enabled leader in revenue cycle management (RCM), practice management, and advisory services for hospital-based physician specialties, is pleased to announce the acquisition of Deras Global Services, a Philippines-based provider of RCM services for hospital-based physician specialties. “The Deras family is proud of the partnership developed with Ventra Health over the past ten years and shares the key value of best-in-class service delivery to clients,” said Deras CEO Will Juras, “I am excited for the personal and professional opportunities available to our dedicated colleagues as the newest member of the Ventra Health family,” added Juras. 

The acquisition represents a key piece of Ventra Health’s global workforce development and service-delivery strategy. The transaction is another move in what has been a busy first quarter for the venerable Physician RCM platform. “Moving fast on accretive opportunities that enhance client delivery and growth is my top priority. We will continue to move aggressively when opportunities present themselves,” said Ventra Health CEO Steven Huddleston. 

Located in the Clark Freeport and Special Economic Zone, the acquisition expands Ventra Health’s footprint into the Philippines with 300+ employees and additional capacity to support significant growth in the future. 

About Ventra Health:

Ventra Health is a leading healthcare organization focused on tech-enabled revenue cycle management, practice management, and advisory solutions for hospital-based physicians. Ventra Health partners with private practices, hospitals, health systems, and physician management organizations to deliver market-leading solutions that solve healthcare providers’ most complex revenue and reimbursement issues. 

Backed by Varsity Healthcare Partners, Ventra Health represents the acquisitions of Abeo, DuvaSawko, Gottlieb, and now Deras Global, who collectively served the emergency medicine, hospital medicine, and anesthesia markets.

SOURCE Ventra Health